A detailed history of Gamma Investing LLC transactions in Dexcom Inc stock. As of the latest transaction made, Gamma Investing LLC holds 5,593 shares of DXCM stock, worth $424,396. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,593
Previous 3,300 69.48%
Holding current value
$424,396
Previous $374 Million 0.21%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$64.0 - $116.06 $146,752 - $266,125
2,293 Added 69.48%
5,593 $375 Million
Q2 2024

Jul 02, 2024

BUY
$110.31 - $140.45 $27,356 - $34,831
248 Added 8.13%
3,300 $374 Million
Q1 2024

Apr 05, 2024

BUY
$114.22 - $140.1 $42,718 - $52,397
374 Added 13.97%
3,052 $423 Million
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $202,162 - $332,500
2,678 New
2,678 $325 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.